An Epistatic Interaction between Themis1 and Vav1 Modulates Regulatory T Cell Function and Inflammatory Bowel Disease Development

被引:13
|
作者
Pedros, Christophe [1 ,2 ,3 ]
Gaud, Guillaume [1 ,2 ,3 ]
Bernard, Isabelle [1 ,2 ,3 ]
Kassem, Sahar [1 ,2 ,3 ]
Chabod, Marianne [1 ,2 ,3 ]
Lagrange, Dominique [1 ,2 ,3 ]
Andreoletti, Olivier [4 ]
Dejean, Anne S. [1 ,2 ,3 ]
Lesourne, Renaud [1 ,2 ,3 ]
Fournie, Gilbert J. [1 ,2 ,3 ]
Saoudi, Abdelhadi [1 ,2 ,3 ]
机构
[1] INSERM, U1043, Unite Mixte Rech, F-31300 Toulouse, France
[2] CNRS, U5282, Unite Mixte Rech, F-31300 Toulouse, France
[3] Univ Toulouse 3, Univ Toulouse, Ctr Physiopathol Toulouse Purpan, F-31300 Toulouse, France
[4] Ecole Natl Vet Toulouse, Inst Natl Rech Agron,Unite Mixte Rech, Ecole Natl Vet Toulouse 1225, Interact Hotes Agents Pathogenes, F-31000 Toulouse, France
来源
JOURNAL OF IMMUNOLOGY | 2015年 / 195卷 / 04期
关键词
RAT-CHROMOSOME; 9; GENETIC INTERACTIONS; NEGATIVE SELECTION; POSITIVE SELECTION; RECEPTOR; PROTEIN; TRANSCRIPTION; ACTIVATION; FAMILY; LAT;
D O I
10.4049/jimmunol.1402562
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of inflammatory diseases depends on complex interactions between several genes and various environmental factors. Discovering new genetic risk factors and understanding the mechanisms whereby they influence disease development is of paramount importance. We previously reported that deficiency in Themis1, a new actor of TCR signaling, impairs regulatory T cell (Treg) function and predisposes Brown-Norway (BN) rats to spontaneous inflammatory bowel disease (IBD). In this study, we reveal that the epistasis between Themis1 and Vav1 controls the occurrence of these phenotypes. Indeed, by contrast with BN rats, Themis1 deficiency in Lewis rats neither impairs Treg suppressive functions nor induces pathological manifestations. By using congenic lines on the BN genomic background, we show that the impact of Themis1 deficiency on Treg suppressive functions depends on a 117-kb interval coding for a R63W polymorphism that impacts Vav1 expression and functions. Indeed, the introduction of a 117-kb interval containing the Lewis Vav1-R63 variant restores Treg function and protects Themis1-deficient BN rats from spontaneous IBD development. We further show that Themis1 binds more efficiently to the BN Vav1-W63 variant and is required to stabilize its recruitment to the transmembrane adaptor LAT and to fully promote the activation of Erk kinases. Together, these results highlight the importance of the signaling pathway involving epistasis between Themis1 and Vav1 in the control of Treg suppressive function and susceptibility to IBD development.
引用
收藏
页码:1608 / 1616
页数:9
相关论文
共 50 条
  • [21] Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans
    Papaleo, F.
    Burdick, M. C.
    Callicott, J. H.
    Weinberger, D. R.
    MOLECULAR PSYCHIATRY, 2014, 19 (03) : 311 - 316
  • [22] Positive regulation of Vav1 by Themis controls CD4 T cell pathogenicity in a mouse model of central nervous system inflammation
    Marrocco, Remi
    Bernard, Isabelle
    Joulia, Emeline
    Barascud, Rebecca
    Dejean, Anne S.
    Lesourne, Renaud
    Saoudi, Abdelhadi
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 81 (01)
  • [23] Positive regulation of Vav1 by Themis controls CD4 T cell pathogenicity in a mouse model of central nervous system inflammation
    Remi Marrocco
    Isabelle Bernard
    Emeline Joulia
    Rebecca Barascud
    Anne S. Dejean
    Renaud Lesourne
    Abdelhadi Saoudi
    Cellular and Molecular Life Sciences, 2024, 81
  • [24] Epistatic interaction between COMT and DTNBP1 modulates prefrontal function in mice and in humans
    F Papaleo
    M C Burdick
    J H Callicott
    D R Weinberger
    Molecular Psychiatry, 2014, 19 : 311 - 316
  • [25] CCR4-dependent regulatory T cell function in inflammatory bowel disease
    Yuan, Qian
    Bromley, Shannon K.
    Means, Terry K.
    Jones, Krister J.
    Hayashi, Fumitaka
    Bhan, Atul K.
    Luster, Andrew D.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (06): : 1327 - 1334
  • [26] Inflammatory effects of galectin-1-deficient regulatory T cells in a T cell transfer model of inflammatory bowel disease
    Lopez-Santalla, M.
    Escribano, O.
    Bueren, J.
    Garin, M. I.
    HUMAN GENE THERAPY, 2013, 24 (12) : A43 - A43
  • [27] G9A MODULATES CHOLESTEROL METABOLISM TO PROMOTE REGULATORY T-CELL DEVELOPMENT AND FUNCTION: IMPLICATIONS TO VACCINE-BASED THERAPIES IN INFLAMMATORY BOWEL DISEASE
    Ramos, Guilherme Piovezani
    Bamidele, Adebowale O.
    Sagstetter, Mary R.
    Klatt, Emily
    Kosinsky, Robyn Laura
    Hamdan, Feda H.
    Gaballa, Joseph
    Neto, Manuel B. Braga
    Kurdi, Ahmed T.
    Westphal, Maria
    Gibbons, Hunter R.
    Nair, Asha
    Osborne, Andrew C.
    Sun, Zhifu
    Johnsen, Steven A.
    Lomberk, Gwen
    Faubion, William
    GASTROENTEROLOGY, 2021, 160 (06) : S235 - S236
  • [28] Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-induced microclusters and is essential in T cell development and activation
    Miletic, Ana V.
    Sakata-Sogawa, Kumiko
    Hiroshima, Michio
    Hamann, Michael J.
    Gomez, Timothy S.
    Ota, Naruhisa
    Kloeppel, Tracie
    Kanagawa, Osami
    Tokunaga, Makio
    Billadeau, Daniel D.
    Swat, Wojciech
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (50) : 38257 - 38265
  • [29] Vav1 Regulates T-Cell Activation through a Feedback Mechanism and Crosstalk between the T-Cell Receptor and CD28
    Helou, Ynes A.
    Petrashen, Anna P.
    Saolomon, Arthur R.
    JOURNAL OF PROTEOME RESEARCH, 2015, 14 (07) : 2963 - 2975
  • [30] MAdCAM-1-Directed CARs Are a Novel Means of Targeting a Regulatory T Cell Therapy for Inflammatory Bowel Disease
    Wang, Jessica
    Park, Soo
    Sengupta, Shouvonik
    O'Brien, Erin
    Cruz, Magelda Montoya
    Bravo, Jazmin
    Chau, Bryant
    Shah, Shairaz
    Goodsell, Amanda
    Zeng, Jennifer
    Wu, Faye
    Tsai, Jordan
    Hsu, Lih-Yun
    Kwong, Brandon
    Borie, Dominic C.
    Greve, Jeffrey
    Lee, John K.
    Kaplan, Charles
    Mahne, Ashley E.
    MOLECULAR THERAPY, 2023, 31 (04) : 713 - 713